Home›Stock Screener›Neuland Laboratories›Quarterly Results

Neuland Laboratories Quarterly Results

Latest Quarter Net Profit
₹213 Cr
QMar 2026
Quarterly Results

Neuland Laboratories quarterly results. In Mar 2026, Neuland Laboratories (NEULANDLAB) reported revenue ₹789 Cr and net profit ₹213 Cr — revenue +134.8% YoY. Review Neuland Laboratories P/E valuation to evaluate earnings-based valuation against sector peers.

NEULANDLAB Quarterly Results — Revenue, Profit & EPS Highlights

Neuland Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check NEULANDLAB market capitalization to track the company's total market size over time.

  • Revenue of ₹789 Cr in Mar 2026 (+21.4% vs Jun 2026, +134.8% vs Mar 2025)
  • Net Profit of ₹213 Cr in Mar 2026 (+43.9% vs Jun 2026, +660.7% vs Mar 2025)
  • EBITDA of ₹320 Cr in Mar 2026 (+38.5% vs Jun 2026)
  • Operating Margin of 40.0% in Mar 2026 (+5.0pp vs Jun 2026)
  • Earnings Per Share of ₹165.76 in Mar 2026 (+44.0% vs Jun 2026)

Neuland Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

NEULANDLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 789 650 516 336 301 21.4% 134.8%
Net Profit (₹ Cr) 213 148 97 28 14 - -
EBITDA (₹ Cr) 320 231 157 59 42 - -
EPS (₹) 165.76 115.10 75.49 21.67 10.83 - -
Operating Margin (%) 40.0% 35.0% 30.0% 16.0% 12.0% - -

NEULANDLAB Share Price Trend — 1-Year Movement Across Quarterly Results

Neuland Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Neuland Laboratories stock price NSE.

Profitability Ratios

Profit Margin 27.0%
EBITDA Margin 40.6%
Operating Margin 40.0%
ROE (Annual) 45.4%

Balance Sheet Highlights

Total Assets ₹2,930 Cr
Total Equity ₹1,875 Cr
Current Assets ₹ Cr
Current Liabilities ₹346 Cr

Cash Flow Analysis

Operating Cash Flow ₹347 Cr
Investing Cash Flow ₹-423 Cr
Financing Cash Flow ₹21 Cr
Net Cash Flow ₹-55 Cr

Current Market Data

Current Price ₹18935.00
Exchange NSE
Last Updated Oct 22, 2026

Revenue Trend (₹ Cr)

Mar 2025 336
Sept 2025 516
Jun 2026 650
Mar 2026 789

Net Profit Trend (₹ Cr)

Mar 2025 28
Sept 2025 97
Jun 2026 148
Mar 2026 213

Operating Margin Trend (%)

Mar 2025 16.0%
Sept 2025 30.0%
Jun 2026 35.0%
Mar 2026 40.0%

NEULANDLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Neuland Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹421,995.00 Cr 1758.0 15,018 2,710 -5.6% - 18.0% 155.6
Divis Laboratories
Mar 2026 		₹241,231.30 Cr 9162.0 2,986 751 -5.0% - 25.2% 323.6
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4615.3 4,111 364 +27.7% +42.2% 8.9% 401.0
Laurus Labs
Mar 2026 		₹111,790.60 Cr 2002.5 1,823 282 -10.5% - 15.5% 387.3
Zydus Life Science
Mar 2026 		₹111,111.95 Cr 1135.0 7,569 1,341 -4.3% - 17.7% 89.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores